Pfizer, Inc., P95 Pharmacovigilance and Epidemiology Services, Pfizer, Inc., P95 Pharmacovigilance and Epidemiology Services, P95 Pharmacovigilance and Epidemiology Services, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Autonomous University of Barcelona - Hospital Universitari Vall d'Hebron, University Hospital Ulm, P95 Pharmacovigilance and Epidemiology Services, P95 Pharmacovigilance and Epidemiology Services, University Hospital Ulm, University of Genova - Department of Health Sciences, Ziekenhuis Netwerk Antwerpen (ZNA), Centre Hospitalier Universitaire St-Pierre, FISABIO-Public Health, Universitat Autònoma de Barcelona (UAB), Instituto de Salud Carlos III, Goethe University Frankfurt, Freiburg University, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc. and P95 Pharmacovigilance and Epidemiology Services

Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. and Pfizer, Inc.

Pfizer, Inc., GERS DATA, GERS DATA, Pfizer, Inc. - Pfize France, Pfizer, Inc. - Pfize France, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. - Pfize France, Pfizer, Inc. - Pfize France, Pfizer, Inc., Pfizer, Inc. - Pfize France, Université de Rennes 1 - Recherche en Pharmaco-épidémiologie et Recours aux Soins (REPERES) and Sorbonne University